Cargando…

Complement activation products in the circulation and urine of primary membranous nephropathy

BACKGROUND: Complement activation plays a substantial role in the pathogenesis of primary membranous nephropathy (pMN). C5b-9, C3c, MBL, and factor B have been documented in the subepithelial immune deposits. However, the changing of complement activation products in circulation and urine is not cle...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Mu-fan, Huang, Jing, Zhang, Yi-miao, Qu, Zhen, Wang, Xin, Wang, Fang, Meng, Li-qiang, Cheng, Xu-yang, Cui, Zhao, Liu, Gang, Zhao, Ming-hui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6688252/ https://www.ncbi.nlm.nih.gov/pubmed/31399080 http://dx.doi.org/10.1186/s12882-019-1509-5

Ejemplares similares

Clinical implications of pathological features of primary membranous nephropathy
por: Zhang, Xiao-dan, et al.
Publicado: (2018)

Patients With Combined Membranous Nephropathy and Focal Segmental Glomerulosclerosis Have Comparable Clinical and Autoantibody Profiles With Primary Membranous Nephropathy: A Retrospective Observational Study
por: Gu, Qiu-hua, et al.
Publicado: (2016)

Rituximab Therapy for Primary Membranous Nephropathy in a Chinese Cohort
por: Gao, Shuang, et al.
Publicado: (2021)

Complement activation profile of patients with primary focal segmental glomerulosclerosis
por: Huang, Jing, et al.
Publicado: (2020)

Clinical Features and Outcomes in Patients With Membranous Nephropathy and Crescent Formation
por: Wang, Jia, et al.
Publicado: (2015)

Low-dose cyclosporine in treatment of membranous nephropathy with nephrotic syndrome: effectiveness and renal safety
por: Yu, Xiaojuan, et al.
Publicado: (2017)

Characteristics of patients with coexisting IgA nephropathy and membranous nephropathy
por: Chen, Pei, et al.
Publicado: (2018)

Complement induces podocyte pyroptosis in membranous nephropathy by mediating mitochondrial dysfunction
por: Wang, Hui, et al.
Publicado: (2022)

Complement Pathways in Membranous Nephropathy: Complex and Multifactorial
por: Brglez, Vesna, et al.
Publicado: (2020)

Proteomic Analysis of Complement Proteins in Membranous Nephropathy
por: Ravindran, Aishwarya, et al.
Publicado: (2020)

Blockage of the lysosome-dependent autophagic pathway contributes to complement membrane attack complex-induced podocyte injury in idiopathic membranous nephropathy
por: Liu, Wei Jing, et al.
Publicado: (2017)

Significance of urine complement proteins in monitoring lupus activity
por: Zhao, Jin, et al.
Publicado: (2022)

Establishing a Case for Anti-complement Therapy in Membranous Nephropathy
por: Ayoub, Isabelle, et al.
Publicado: (2020)

Non-diabetic urine glucose in idiopathic membranous nephropathy
por: Liu, Lingling, et al.
Publicado: (2022)

The classical pathway triggers pathogenic complement activation in membranous nephropathy
por: Seifert, Larissa, et al.
Publicado: (2023)

Investigation of the Mechanism of Complement System in Diabetic Nephropathy via Bioinformatics Analysis
por: Xu, Bojun, et al.
Publicado: (2021)

The role of the complement system in primary membranous nephropathy: A narrative review in the era of new therapeutic targets
por: So, Benjamin Y. F., et al.
Publicado: (2022)

Implication of Urinary Complement Factor H in the Progression of Immunoglobulin A Nephropathy
por: Liu, Maojing, et al.
Publicado: (2015)

Urine proteomics of primary membranous nephropathy using nanoscale liquid chromatography tandem mass spectrometry analysis
por: Pang, Lu, et al.
Publicado: (2018)

Complement Activation Is Associated With Crescents in IgA Nephropathy
por: Wang, Zi, et al.
Publicado: (2021)

Association of circulating proprotein convertase subtilisin/kexin type 9 concentration with coagulation abnormalities in patients with primary membranous nephropathy
por: Zhu, Huizi, et al.
Publicado: (2023)

Advances in the Management of Primary Membranous Nephropathy and Rituximab-Refractory Membranous Nephropathy
por: Teisseyre, Maxime, et al.
Publicado: (2022)

M2 Macrophage Subpopulations in Glomeruli Are Associated With the Deposition of IgG Subclasses and Complements in Primary Membranous Nephropathy
por: Hu, Wenxue, et al.
Publicado: (2021)

Urine anti-PLA2R antibody is a novel biomarker of idiopathic membranous nephropathy
por: Wang, Yu, et al.
Publicado: (2017)

Mechanisms of Primary Membranous Nephropathy
por: Gu, Yan, et al.
Publicado: (2021)

Editorial: Primary membranous nephropathy
por: Infantino, Maria
Publicado: (2022)

Dissecting the relationships of IgG subclasses and complements in membranous lupus nephritis and idiopathic membranous nephropathy
por: Na, Woong, et al.
Publicado: (2017)

Molecular characteristics of circulating B cells and kidney cells at the single-cell level in special types of primary membranous nephropathy
por: Feng, Xiaoqian, et al.
Publicado: (2023)

Concurrent IgA Nephropathy and Membranous Nephropathy, Is It an Overlap Syndrome?
por: He, Jia-Wei, et al.
Publicado: (2022)

Differential expression study of circular RNAs in exosomes from serum and urine in patients with idiopathic membranous nephropathy
por: Ma, Hualin, et al.
Publicado: (2019)

Nomogram to predict the progression of patients with primary membranous nephropathy and nephrotic syndrome
por: Liu, Lili, et al.
Publicado: (2021)

Primary membranous nephropathy in two siblings with one combined with anti-glomerular basement membrane disease: a case report
por: Cheng, Yan-jiao, et al.
Publicado: (2023)

Rapid diagnosis of membranous nephropathy based on serum and urine Raman spectroscopy combined with deep learning methods
por: Zhang, Xueqin, et al.
Publicado: (2023)

A nomogram prediction model for treatment failure in primary membranous nephropathy
por: Geng, Chanyu, et al.
Publicado: (2023)

Corrigendum: Concurrent IgA nephropathy and membranous nephropathy, is it an overlap syndrome?
por: He, Jia-Wei, et al.
Publicado: (2023)

Clinicopathological features and prognosis of primary membranous nephropathy in combination with crescent
por: Pan, Yan, et al.
Publicado: (2023)

Primary Membranous Glomerulonephritis: The Role of Serum and Urine Biomarkers in Patient Management
por: Maifata, Sadiq Mu’azu, et al.
Publicado: (2019)

Plasma exchange and rituximab treatments in primary membranous nephropathy combined with crescentic glomerulonephritis: A case report
por: Lu, Hui, et al.
Publicado: (2019)

The characters of antibodies against PLA2R in healthy individuals and in the patient with PLA2R associated membranous nephropathy
por: Cheng, Yan-jiao, et al.
Publicado: (2023)

Construction of a Nomogram Discriminating Malignancy-Associated Membranous Nephropathy From Idiopathic Membranous Nephropathy: A Retrospective Study
por: Wang, Ting, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6kbtiheditpk045opj30rul5rf